Endocrinology

What can you do when seeing a patient costs more than his or her insurance pays you?

The annual meeting of the American Diabetes Association provided many studies looking at the condition from a variety of angles. What doctors did with those results when they went back to their practices was up to them.

As patients with diabetes progress throughout their lives there may be a need to increase treatment to help manage their symptoms. A recent study looked at how likely patients are to intensify their treatment and what that can mean for their care.

Patients with diabetes face many challenges over the course of a day, not the least of which is ensuring their blood glucose levels stay in a safe range. Technological advances have helped make this an easier obstacle to overcome.

While technology is helping patients with diabetes improve their quality of life there is only so much that technology and their health care providers can do for them. In many ways a patient can and must now play a larger role in their overall care.

With so many patients dealing with diabetes on a daily basis the burden of trying to help can be too much for even the biggest and most advanced companies. By working together they can not only reach more patients but also provide a higher level of care.

Although intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents has become the therapeutic mainstay for diabetic macular edema and neovascular age-related macular degeneration, it poses a risk of noninfectious uveitis or infectious endopthalmitis.

A retrospective analysis of diabetes and prediabetes diagnoses found that screening guidelines from the United States Preventative Service Task Force (USPSTF) would have detected less than half of all cases that were discovered.

Diabetes may have its roots in endocrinology but in recent years it has proven to be an issue affecting specialities across medicine. Because of that it takes more than one specialist to provide the best possible care for patients with the condition.

At the recent American Diabetes Association annual meeting Lilly Diabetes had more than 60 disclosures discussing their latest work in the field. Of all that work the Mosaic study was arguably the biggest news to come out of New Orleans.

It's time to redirect the initial evaluation of low- to intermediate-risk patients presenting with symptoms suggestive of CAD back to the primary care and internal medicine setting.

Analysis of 2 large health worker cohorts suggests that people can reduce their risk of developing diabetes by preparing more of their meals at home.

Approximately 60% of physicians in the US will be sued for malpractice, research and statistics have found.

While public health organizations used to recommend low-fat/low-calories diets for people seeking to lose weight, in recent years, low-carbohydrate diets have been shown to be effective.

While lifestyle medicine may not be at the forefront of the field today those who practice it believe it can be an invaluable tool in the future.

Lifestyle modifications has become a popular phrase throughout medicine. However, telling patients about changes they should make and ensuring they make those changes are two very different issues in most cases.

The USDA defines low food security as “reports of reduced quality, variety, or desirability of diet. Little or no indication of reduced food intake.”

As healthcare professionals are well aware, more than 9% of Americans have diabetes, and most have type 2 diabetes.

Physicians and nurses have both an ethical and a legal obligation to ensure a patient will be discharged safely.

How often do you have to manage inappropriate and unnecessary inpatient consults? Is there a way to fix the system?

Doctors treating patients for a variety of conditions may all have the same goals in helping the patient but may have difficulty communicating those goals with their colleagues.

Placement of the Ozurdex sustained-release dexamethasone implant in 29 patients with persistent diabetic macular edema resulted in a significant improvement in visual acuity and a significant decrease in central macular thickness 6 months after implantation.

Veterans are twice as likely to become chronically homeless as other Americans. People who have been in military service make up about 11% of the US homeless population. The good news is that people are trying to help.

Glucagon-like peptide 1 (GLP-1) agonists are highly potent second-line agents for type 2 diabetes, protecting and improving beta-cell function and have a favorable adverse effect profile.

The Food and Drug Administration (FDA) has approved five weight loss medications in the United States indicated for patients with a BMI measurement over 30 kg/m2 or over 27 kg/m2 and at least one weight-associated comorbidity.

On a global scale each year, half the number type 2 diabetics are undiagnosed with the average age of onset steadily falling.

Type 2 diabetes increases the risk of both nocturnal intermittent hypoxia and sleep fragmentation, and type 2 diabetics are up to 20 times more likely to suffer from sleep apnea-hypopnea syndrome.

The Food and Drug Administration (FDA) recently approved insulin glargine U-300 (Toujeo®), and insulin lispro U-200 (Humalog® U-200).

The MD Magazine editors rounded up the 10 best stories from June – did you read them all?

In patients diagnosed with psoriasis, disease severity has been strongly associated with developing a higher risk of comorbidities affecting the kidney, liver, and pancreas.